Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T04:45:53.358Z Has data issue: false hasContentIssue false

Does a plasma level of chlorpromazine help?

Published online by Cambridge University Press:  09 July 2009

Theodore van Putten*
Affiliation:
Veterans Administration Medical Center, Brentwood, California, USA, Neuropsychiatric Institute and the Department of Pharmacology, UCLA School of Medicine, California, USA
Philip R. A. May
Affiliation:
Veterans Administration Medical Center, Brentwood, California, USA, Neuropsychiatric Institute and the Department of Pharmacology, UCLA School of Medicine, California, USA
Donald J. Jenden
Affiliation:
Veterans Administration Medical Center, Brentwood, California, USA, Neuropsychiatric Institute and the Department of Pharmacology, UCLA School of Medicine, California, USA
*
1 Address for correspondence: Dr T. Van Putten, Veterans Administration Medical Center, Brentwood, Wilshire and Sawtelle Boulevards, Los Angeles, Ca 90073, USA.

Synopsis

Forty-eight newly admitted schizophrenic patients were treated with a fixed, conservative (6·6 mg/kg) dose of chlorpromazine (CPZ) for 28 days. CPZ plasma levels were measured by a gas chromatography mass spectrometry method (GCMS) using 2H6-chlorpromazine as an internal standard. At the end of the fixed-dose period, ‘responders’ had the same plasma levels as ‘non-responders’, suggesting that lack of response is primarily a matter of the illness' sensitivity to CPZ, not to a plasma level below some therapeutic window. After the fixed-dose period, the dosage of CPZ was increased in the ‘non-responders’ by physician's choice. Improvement occurred over a wide range of 10–225 picomoles (3–72 ng)/ml. Above 300 picomoles (95 ng/ml) 4 inaccessible patients eventually became much worse, suggesting psychotoxicity. It is in the inaccessible patient whose illness is only minimally, or not at all, sensitive to CPZ that a plasma level might be especially useful.

Interpretation of plasma levels is complicated by the speed of response: some initial non-responders improved by the 56th day of treatment on very conservative plasma levels.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1981

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable